Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | CA9 | Q16790 | 4/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.40 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | PLG | P00747 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.38 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | PADI6 | Q6TGC4 | 1/20 | 0.37 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.36 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 2/20 | 0.36 |
| ▸ | CASP3 | P42574 | 2/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13045375 | 0.98 | CA12 (0.46) | CA12CA1CA2CA9FOLH1 | |
| SCHEMBL16299321 | 0.94 | CA12 (0.52) | CA12CA1CA2CA9FOLH1 | |
| SCHEMBL16329974 | 0.94 | CA12 (0.52) | CA12CA1CA2CA9FOLH1 | |
| SCHEMBL16330002 | 0.94 | CA12 (0.52) | CA12CA1CA2CA9FOLH1 | |
| SCHEMBL13045419 | 0.91 | CA12 (0.54) | CA12CA1CA2CA9FOLH1 | |
| SCHEMBL12387563 | 0.89 | CA12 (0.41) | CA12CA1CA2CA9FOLH1 | |
| SCHEMBL12387482 | 0.89 | CA12 (0.41) | CA12CA1CA2CA9FOLH1 | |
| SCHEMBL12387458 | 0.88 | CA12 (0.44) | CA12CA1CA2CA9FOLH1 | |
| SCHEMBL10085160 | 0.87 | TDP1 (0.44) | CA12CA1CA2CA9FOLH1 | |
| SCHEMBL13045392 | 0.85 | FOLH1 (0.43) | FOLH1TDP1PLGPRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120027677-A1 | Prion-specific peptoid reagents | NOVARTIS AG | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120027677-A1 | Prion-specific peptoid reagents | PRNP, PARL, PCNP | CA12 3330/4885CA1 2710/4885CA2 3429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.